Physiologic dysfunction of the esophagus

Modern Surgical Care: Physiologic Foundations and Clinical Applications, Third Edition

Volumn 1, Issue , 2006, Pages 295-332

  Hamoui, Nahid ^a   Crookes, Peter F ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 68649128004     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (130)

1. Eslick GD, Talley NJ. Non-cardiac chest pain: predictors of health care seeking, the types of health care professional consulted, work absenteeism and interruption of daily activities. Aliment Pharmacol Ther 2004; 20:909-915.
2. Malagelada JR. Review article: supra-oesophageal manifestations of gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2004; 19(suppl 1):43-48.
3. D’Urzo A, Jugovic P. Chronic cough. Three most common causes. Can Family Physician 2002; 48:1311-1316.
4. Theodoropoulos DS, Pecoraro DL, Efstratiadis SE. The association of gastroesophageal reflux disease with asthma and chronic cough in the adult. Am J Respir Med 2002; 1:133-146.
5. Corso MJ, Pursnani KG, Mohiuddin MA, et al. Globus sensation is associated with hypertensive upper esophageal sphincter but not with gastroesophageal reflux. Dig Dis Sci 1998; 43:1513-1517.
6. Hewson EG, Ott DJ, Dalton CB, Chen YM, Wu WC, Richter JE. Manometry and radiology. Complementary studies in the assessment of esophageal motility disorders. Gastroenterology 1990; 98:626-632.
7. Ott DJ, Hodge RG, Pikna LA, Chen MY, Gelfand DW. Modified barium swallow: clinical and radiographic correlation and relation to feeding recommendations. Dysphagia 1996; 11:187-190.
8. Jones WG II, Ginsberg RJ. Esophageal perforation: a continuing challenge. Ann Thorac Surg 1992; 53:534-553.
9. Hill LD, Kozarek RA, Kraemer SJ, et al. The gastroesophageal flap valve: in vitro and in vivo observations. Gastrointest Endosc 1996; 44:541-547.
10. von Rahden BH, Stein HJ, Becker K, Liebermann-Meffert D, Siewert JR. Heterotopic gastric mucosa of the esophagus: literature-review and proposal of a clinicopathologic classification. Am J Gastroenterol 2004; 99:543-551.
11. Schoeman MN, Tippett MD, Akkermans LM, Dent J, Holloway RH. Mechanisms of gastroesophageal reflux in ambulant healthy human subjects. Gastroenterology 1995; 108:83-91.
12. Zaninotto G, DeMeester TR, Schwizer W, Johansson K-E, Cheng SC. The lower esophageal sphincter in health and disease. Am J Surg 1988; 155:104-111.
13. Kahrilas PJ, Dodds WJ, Hogan WJ. Effect of peristaltic dysfunction on esophageal volume clearance. Gastroenterology 1988; 94:73-80.
14. Mason RJ, Bremner CG, DeMeester TR, et al. Pharyngeal swallowing disorders: selection for and outcome after myotomy. Ann Surg 1998; 228:598-608.
15. Streets CG, DeMeester TR. Ambulatory 24-hour esophageal pH monitoring: why, when, and what to do. J Clin Gastroenterol 2003; 37:14-22.
16. Pandolfino JE. Bravo capsule pH monitoring. Am J Gastroenterol 2005; 100:8-10.
17. Dobhan R, Castell DO. Normal and abnormal proximal esophageal acid exposure: results of ambulatory dual-probe pH monitoring. Am J Gastroenterol 1993; 88:25-29.
18. Bechi P, Cianchi F. Technical aspects and clinical indications of 24-hour intragastric bile monitoring. Hepato-Gastroenterology 1999; 46:54-59.
19. Vaezi MF, Richter JE. Duodenogastroesophageal reflux and methods to monitor nonacidic reflux. Am J Med 2001; 111(suppl 8A):160S-168S.
20. Tutuian R, Vela MF, Shay SS, Castell DO. Multichannel intraluminal impedance in esophageal function testing and gastroesophageal reflux monitoring. J Clin Gastroenterol 2003; 37:206-215.
21. Shay S, Tutuian R, Sifrim D, et al. Twenty-four hour ambulatory simultaneous impedance and pH monitoring: a multicenter report of normal values from 60 healthy volunteers. Am J Gastroenterol 2004; 99:1037-1043.
22. Balaji NS, Crookes PF, Banki F, Hagen JA, Ardill JE, DeMeester TR. A safe and noninvasive test for vagal integrity revisited. Arch Surg 2002; 137:954-958.
23. DeVault KR, Swain JM, Wentling GK, Floch NR, Achem SR, Hinder RA. Evaluation of vagus nerve function before and after antireflux surgery. J Gastrointest Surg 2004; 8:883-888.
24. Delaney BC. Review article: prevalence and epidemiology of gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2004; 20(suppl 8):2-4.
25. Cremonini F, Di Caro S, Delgado-Aros S, et al. Meta-analysis: the relationship between, Helicobacter pylori infection and gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2003; 18:279-289.
26. Mittal RK, McCallum RW. Characteristics of transient lower esophageal sphincter relaxation in humans. Am J Physiol 1987; 252(5 Pt 1):G636-G641.
27. Allison PR. Reflux esophagitis, sliding hiatal hernia, and the anatomy of repair. Surg Gynecol Obstet 1951; 92:419.
28. Cohen S, Harris LD. Does hiatus hernia affect competence of the gastroesophageal sphincter? N Engl J Med 1971; 284(19): 1053-1056.
29. Sloan S, Rademaker AW, Kahrilas PJ. Determinants of gastroesophageal junction incompetence: hiatal hernia, lower esophageal sphincter, or both? Ann Intern Med 1992; 117: 977-982.
30. Patti MG, Goldberg HI, Arcerito M, Bortolasi L, Tong J, Way LW. Hiatal hernia size affects lower esophageal sphincter function, esophageal acid exposure, and the degree of mucosal injury. Am J Surg 1996; 171:182-186.
31. Mittal RK, Lange RC, McCallum RW. Identification and mechanism of delayed esophageal clearance in subjects with hiatus hernia. Gastroenterology 1987; 92:130-135.
32. Fletcher J, Wirz A, Young J, Vallance R, McColl KE. Unbuffered highly acidic gastric juice exists at the gastroesophageal junction after a meal. Gastroenterology 2001; 121:775-783.
33. Fletcher J, Wirz A, Henry E, McColl KE. Studies of acid exposure immediately above the gastro-oesophageal squamocolumnar junction: evidence of short segment reflux. Gut 2004; 53:168-173.
34. DeMeester TR, O’Sullivan GC, Bermudez G, Midell AI, Cimchowski GE, O’Drobinak J. Esophageal function in patients with angina like chest pain and normal coronary angiograms. Ann Surg 1982; 196; 488-498.
35. Lundell LR, Dent J, Bennett JR, et al. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut 1999; 45: 172-180.
36. Savary M, Miller G. The Oesophagus Handbook and Atlas of Endoscopy. Solothurn, Switzerland: Verlag Glassmann AG, 1978.
37. Ismail-Beigi F, Horton PF, Pope CE II. Histological consequences of gastroesophageal reflux in man. Gastroenterology 1970; 58:163-174.
38. Chandrasoma PT, Der R, Ma Y, Dalton P, Taira M. Histology of the gastroesophageal junction: an autopsy study. Am J Surg Pathol 2000; 24:402-409.
39. Kilgore SP, Ormsby AH, Gramlich TL, et al. The gastric cardia: fact or fiction? Am J Gastroenterol 2000; 95:921-924.
40. Lundell L, Miettinen P, Myrvold HE, et al. Continued (5-year) follow-up of a randomised clinical study comparing antireflux surgery and omeprazole in gastroesophageal reflux disease. J Am Coll Surg 2001; 192:172-179.
41. Spechler SJ, Lee E, Ahnen D, et al. Long-term outcome of medical and surgical therapies for gastroesophageal reflux disease. JAMA 2001; 285:2331-2338.
42. Campos GM, Peters JH, DeMeester TR, et al. Multivariate analysis of factors predicting outcome after laparoscopic Nissen fundoplication. J Gastrointest Surg 1999; 3:292-300.
43. Fernando HC, Schauer PR, Rosenblatt M, et al. Quality of life after antireflux surgery compared with nonoperative management for severe gastroesophageal reflux disease. J Am Coll Surg 2002; 194:23-27.
44. Streets CG, DeMeester SR, DeMeester TR, et al. Excellent quality of life after Nissen fundoplication depends on successful elimination of reflux symptoms and not the invasiveness of the surgical approach. Ann Thorac Surg 2002; 74: 1019-1024.
45. Triadafilopoulos G. Stretta: an effective, minimally invasive treatment for gastroesophageal reflux disease. Am J Med 2003; 115(suppl 3A):192S-200S.
46. Bowrey DJ, Peters JH. Current state, techniques, and results of laparoscopic antireflux surgery. Sem Laparosc Surg 1999; 6: 194-212.
47. Soper NJ, Dunnegan D. Anatomic fundoplication failure after laparoscopic antireflux surgery. Ann Surg 1999; 229: 669-676.
48. Targarona EM, Bendahan G, Balague C, Garriga J, Trias M. Mesh in the hiatus: a controversial issue. Arch Surg 2004; 139:1286-1296.
49. Schauer PR, Meyers WC, Eubanks S, Norem RF, Franklin M, Pappas TN. Mechanisms of gastric and esophageal perforations during laparoscopic Nissen fundoplication. Ann Surg 1996; 223:43-52.
50. Watson DI, Jamieson GG, Mitchell PC, Devitt PG, Britten- Jones R. Stenosis of the esophageal hiatus following laparoscopic fundoplication. Arch Surg 1995; 130:1014-1016.
51. Yau P, Watson DI, Devitt PG, Game PA, Jamieson GG. Early reoperation following laparoscopic antireflux surgery. Am J Surg 2000; 179:172-176.
52. Zaninotto G, DeMeester TR, Bremner CG, Smyrk TC, Cheng S-C. Esophageal function in patients with reflux-induced strictures and its relevance to surgical treatment. Ann Thorac Surg 1989; 47:362-370.
53. Pezzullo JC, Lewicki AM. Schatzki ring, statistically reexamined. Radiology 2003; 228:609-613.
54. Jamieson JR, Hinder RA, DeMeester TR, Litchfield D, Barlow AP, Bailey RT. Analysis of thirty-two patients with Schatzki’s ring. Am J Surg 1989; 158:563-566.
55. Demeester SR, Peters JH, Demeester TR. Barrett’s esophagus. Curr Prob Surg 2001; 38:558-640.
56. Martinez de Haro L, Ortiz A, Parrilla P, et al. Intestinal metaplasia in patients with columnar lined esophagus is associated with high levels of duodenogastroesophageal reflux. Ann Surg 2001; 233:34-38.
57. Schnell TH, Sontag SJ, Chejifec G. Adenocarcinoma arising in tongues or short segments of Barrett’s esophagus. Dig Dis Sci 1992; 37:137.
58. Jenkins GJ, Doak SH, Parry JM, D’Souza FR, Griffiths AP, Baxter JN. Genetic pathways involved in the progression of Barrett’s metaplasia to adenocarcinoma. Br J Surg 2002; 89:824-837.
59. Parrilla P, Martinez de Haro LF, Ortiz A, et al. Long-term results of a randomized prospective study comparing medical and surgical treatment of Barrett’s esophagus. Ann Surg 2003; 237:291-298.
60. McDonald ML, Trastek VF, Allen MS, Deschamps C, Pairolero PC, Pairolero PC. Barretts’s esophagus: does an antireflux procedure reduce the need for endoscopic surveillance? J Thorac Cardiovasc Surg 1996; 111:1135-1138.
61. Wang KK, Sampliner RE. Mucosal ablation therapy of Barrett esophagus. Mayo Clin Proc 2001; 76:433-437.
62. Sampliner RE and the Practice Parameters Committee of the American College of Gastroenterology. Practice guidelines on the diagnosis, surveillance, and therapy of Barrett’s esophagus. Am J Gastroenterol 1998; 93:1028-1032.
63. Provenzale D, Schmitt C, Wong JB. Barrett’s esophagus: a new look at surveillance based on emerging estimates of cancer risk. Am J Gastroenterol 1999; 94:2043-2053.
64. Montgomery E, Bromner MP, Goldblum JR, et al. Reproducibility of the diagnosis of dysplasia in Barrett’s esophagus. Hum Pathol 2001; 32:368-378.
65. Horvath KD, Swanstrom LL, Jobe BA. The short esophagus: pathophysiology, incidence, presentation, and treatment in the era of laparoscopic antireflux surgery. Ann Surg 2000; 232:630-640.
66. Ritter MP, Peters JH, DeMeester TR, et al. Treatment of advanced gastroesophageal reflux disease with Collis gastroplasty and Belsey partial fundoplication. Arch Surg 1998; 133:523-529.
67. Oleynikov D, Eubanks TR, Oelschlager BK, Pellegrini CA. Total fundoplication is the operation of choice for patients with gastroesophageal reflux and defective peristalsis. Surg Endosc 2002; 16:909-913.
68. Patti MG, Robinson T, Galvani C, Gorodner MV, Fisichella PM, Way LW. Total fundoplication is superior to partial fundoplication even when esophageal peristalsis is weak. J Am Coll Surg 2004; 198:863-869.
69. Perez AR, Moncure AC, Rattner DW. Obesity adversely affects the outcome of antireflux operations. Surg Endosc 2001; 15:986-989.
70. Fraser J, Watson DI, O’Boyle CJ, Jamieson GG. Obesity and its effect on outcome of laparoscopic Nissen fundoplication. Dis Esoph 2001; 14:50-53.
71. Tsai P, Peters J, Johnson W, Cohen R, Starnes V. Laparoscopic fundoplication 1 month prior to lung transplantation. Surg Endosc 1996; 10:668-670.
72. Lord RV, Kaminski A, Oberg S, et al. Absence of gastroesophageal reflux disease in a majority of patients taking acid suppression medications after Nissen fundoplication. J Gastrointest Surg 2002; 6:3-9.
73. Papasavas PK, Yeaney WW, Landreneau RJ, et al. Reoperative laparoscopic fundoplication for the treatment of failed fundoplication. J Thorac Cardiovasc Surg 2004; 128:509-516.
74. Noel RJ, Putnam PE, Rothenberg ME. Eosinophilic esophagitis. N Engl J Med 2004; 351(9):940-941.
75. van Overbeek JJ. Pathogenesis and methods of treatment of Zenker’s diverticulum. Ann Otol Rhinol Laryngol 2003; 112: 583-593.
76. Spechler SJ, Castell DO. Classification of oesophageal motility abnormalities. Gut 2001; 49:145-151.
77. Paterson WG. Etiology and pathogenesis of achalasia. Gastrointest Endosc Clin N Am 2001; 11:249-266, vi.
78. Awad ZT, Selima MA, Filipi CJ. Pseudoachalasia as a late complication of gastric wrap performed for morbid obesity: report of a case. Surg Today 2002; 32:906-909.
79. Stylopoulos N, Bunker CJ, Rattner DW. Development of achalasia secondary to laparoscopic Nissen fundoplication. J Gastrointest Surg 2002; 6:368-376.
80. Wiesner W, Hauser M, Schob O, Weber M, Hauser RS. Pseudo-achalasia following laparoscopically placed adjustable gastric banding. Obes Surg 2001; 11:513-518.
81. Neubrand M, Scheurlen C, Schepke M, Sauerbruch T. Longterm results and prognostic factors in the treatment of achalasia with botulinum toxin. Endoscopy 2002; 34:519-523.
82. Eckardt VF, Gockel I, Bernhard G. Pneumatic dilation for achalasia: late results of a prospective follow up investigation. Gut 2004; 53:629-633.
83. Patti MG, Pellegrini CA, Horgan S, et al. Minimally invasive surgery for achalasia: an 8-year experience with 168 patient. Ann Surg 1999; 230:587-593.
84. Wiechmann RJ, Ferguson MK, Naunheim KS, et al. Videoassisted surgical management of achalasia of the esophagus. J Thorac Cardiovasc Surg 1999; 118:916-923.
85. Richards WO, Torquati A, Holzman MD, et al. Heller myotomy versus Heller myotomy with Dor fundoplication for achalasia: a prospective randomized double-blind clinical trial. Ann Surg 2004; 240:405-412.
86. Zaninotto G, Costantini M, Molena D, et al. Treatment of esophageal achalasia with laparoscopic Heller myotomy and Dor partial anterior fundoplication: prospective evaluation of 100 consecutive patients. J Gastrointest Surg 2000; 4: 282-289.
87. de Oliveira JM, Birgisson S, Doinoff C, et al. Timed barium swallow: a simple technique for evaluating esophageal emptying in patients with achalasia. AJR 1997; 169:473-479.
88. Mineo TC, Pompeo E. Long-term outcome of Heller myotomy in achalasie sigmoid esophagus. J Thorac Cardiovasc Surg 2004; 128:402-407.
89. Almogy G, Anthone GJ, Crookes PF. Achalasia in the context of morbid obesity: a rare but important association. Obes Surg 2003; 13:896-900.
90. Anderson KO, Dalton CB, Bradley LA, Richter JE. Stress induces alterations of esophageal pressures in healthy volunteers and non-cardiac chest pain patients. Dig Dis Sci 1989; 34:83-91.
91. Champion JK, Delise N, Hunt T. Myenteric plexus in spastic motility disorders. J Gastrointest Surg 2001; 5:514-516.
92. Peters LJ, Mass LC, Petty D, et al. Spontaneous non-cardiac chest pain: evaluation by 24 hour ambulatory esophageal motility and pH monitoring. Gastroenterology 1988; 94:878-886.
93. Richter JE, Castell DO. Diffuse esophageal spasm: a reappraisal. Ann Intern Med 1984; 100:242-245.
94. DiMarino Al Jr, Cohen S. Characteristics of lower esophageal function in symptomatic diffuse esophageal spasm. Gastroenterology 1997; 66:1-6.
95. Orlando RC, Bozymski EM. Clinical and manometric effects of nitroglycerin in diffuse esophageal spasm. N Engl J Med 1973; 289:23-25.
96. Davies HA, Lewis MJ, Rhodes J, Henderson AH. Trial of nifedipine for prevention of esophageal spasm. Digestion 1987; 36:81-83.
97. Hongo M, Traube M, McCallum RW. Comparison of effects of nifedipine, probantheline bromide, and the combination on esophageal motor function in normal volunteers. Dig Dis Sci 1984; 29:300-305.
98. Eherer AJ, Schwetz I, Hammer HF, et al. Effect of sildenafil on oesophageal motor function in health subjects and patients with oesophageal motor disorders. Gut 2002; 50:758-764.
99. Cannon RO, Quyyumi AA, Mincemoyer R, et al. Imipramine in patients with chest pain despite normal coronary angiograms. N Engl J Med 1994; 330:1411-1417.
100. Ebert EC, Ouyang A, Wright SH, Cohen S. Pneumatic dilation in patients with symptomatic diffuse esophageal spasmand lower esophageal sphincter dysfunction. Dig Dis Sci 1983; 28:481-485.
101. Fishman VM, Parkman HP, Schiano TD, et al. Symptomatic improvement in achalasia after botulinum toxin of the lower esophageal sphincter. Am J Gastroenterol 1996; 91:1724-1730.
102. Henderson RD, Ryder D, Marryatt G. Extended esophageal myotomy and short total fundoplication hernia repair in diffuse esophageal spasm: five-year review in 34 patients. Ann Thorac Surg 1987; 43:25-31.
103. Eypasch EP, DeMeester TR, Klingman RR, Stein HJ. Physiologic assessment and surgical management of diffuse esophageal spasm. J Thorac Cardiovasc Surg 1992; 104:859-868.
104. Leite LP, Johnston BT, Barrett J, et al. Ineffective esophageal motility (IEM): the primary finding in patients with nonspecific esophageal motility disorder. Dig Dis Sci 1997; 42: 1853-1858.
105. Fouad YM, Katz PO, Hatlebakk JG, Castell DO. Ineffective esophageal motility: the most common motility abnormality in patients with GERD-associated respiratory symptoms. Am J Gastroenterol 1999; 94(6):1464-1467.
106. Lock G, Holstege A, Lang B, Scholmerich J. Gastrointestinal manifestations of progressive systemic sclerosis. Am J Gastroenterol 1997; 92:763-771.
107. Estrera A, Taylor W, Mills LJ, Platt MR. Corrosive burns of the esophagus and stomach: a recommendation for an aggressive surgical approach. Ann Thorac Surg 1986; 41:276-283.
108. Tran Ba Huy P, Celerier M. Management of severe caustic stenosis of the hypopharynx and esophagus by ileocolic transposition via suprahyoid or transepiglottic approach. Analysis of 18 cases. Ann Surg 1988; 207:439-445.
109. Anderson KD, Rouse TM, Randolph JG. A controlled trial of corticosteroids in children with corrosive injury of the esophagus. N Engl J Med 1990; 323:637-640.
110. Cameron JL, Keffer RF, Hendrix TR, Mehigan DG, Baker RR. Selective non-operative management of contained intra-thoracic esophageal perforations. Ann Thorac Surg 1979; 27: 404-408.
111. Hall ML, Huseby JS. Hemorrhagic pulmonary edema associated with meat tenderizer treatment for esophageal meat impaction. Chest 1988; 94:640-642.
112. Lee LS, Singhal S, Brinster CJ, et al. Current management of esophageal leiomyoma. J Am Coll Surg 2004; 198: 136-146.
113. Bollschweiler E, Wolfgarten E, Gutschow C, Holscher AH. Demographic variations in the rising incidence of esophageal adenocarcinoma in white males. Cancer 2000; 92:549-555.
114. Lagergren J. Adenocarcinoma of oesophagus: what exactly is the size of the problem and who is at risk? Gut 2005; 54:i1-i5.
115. Pohl H, Welch HG. The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Can Inst 2005; 97:142-146.
116. Van Dam J. Endosonographic evaluation of the patient with esophageal cancer. Chest 1997; 112(suppl):184S-190S.
117. Nigro JJ, Hagen JA, DeMeester TR, et al. Prevalence and location of nodal metastases in distal esophageal adenocarcinoma confined to the wall: implications or therapy. J Thorac Cardiovasc Surg 1999; 117:16-25.
118. Hardwick RH, Williams GT. Staging of oesophageal adenocarcinoma. Br J Surg 2002; 89:1076-1077.
119. Siewert JR, Stein HJ, Fink U. Surgical resection for cancer of the cardia. Semin Surg Oncol 1999; 17:125-131.
120. Heitmeiller RF, Redmond M, Hamilton SR. Barrett’s esophagus with high-grade dysplasia: an indication for prophylactic esophagectomy. Ann Surg 1996; 224:66-71.
121. Banki F, Mason R, DeMeester SR, et al. Vagal-sparing esophagectomy: a more physiologic alternative. Ann Surg 2002; 236:324-336.
122. Hagen JA, DeMeester SR, Peters JH, Chandrasoma P, DeMeester T. Curative resection for esophageal adenocarcinoma: analysis of 100 en bloc esophagectomies. Ann Surg 2001; 234:520-531.
123. DeMeester TR, Johansson K-E, Franze I, et al. Indications, surgical technique, and long-term functional results of colon interposition or bypass. Ann Surg 1988; 208:460-474.
124. Stewart JR, Hoff SJ, Johnson DH, et al. Improved survival with neoadjuvant therapy and resection for adenocarcinoma of the esophagus. Ann Surg 1993; 218:571-576.
125. Ferguson MK, Reeder LB, Hoffman PC, Haraf DJ, Drinkard LC, Vokes EE I. Intensive multimodality therapy for carcinoma of the esophagus and gastroesophageal junction. Ann Surg Oncol 1995; 2:101-106.
126. Visser BC, Venook AP, Patti MG. Adjuvant and neoadjuvant therapy for esophageal cancer: a critical reappraisal. Surg Oncol 2003; 12:1-7.
127. Walsh TN, Noonan N, Hollywood D, Kelly A, Keeling N, Hennessy TPJ. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 1996; 335:462-467.
128. Harpole DH, Moore M, Herndon JE, et al. The prognostic value of molecular marker analysis in patients treated with trimodality therapy for esophageal cancer. Clin Cancer Res 2001; 7:562-569.
129. Patti MG, Corvera CU, Glasgow RE, Way LW. A hospital’s annual rate of esophagectomy influences the operative mortality rate. J Gastrointest Surg 1998; 2:186-192.
130. Dimick JB, Pronovost PJ, Cowan JA, Lipsett PA. Surgical volume and quality of care for esophageal resection: do high-volume hospitals have fewer complications? Ann Thorac Surg 2003; 75:337-341